FL3 (flavagline)
FL3 (flavagline) is a synthetic flavagline derivative that has been extensively studied for its potential therapeutic applications in oncology and neurology. It is known for its potent anti-cancer and neuroprotective properties.
Chemistry[edit | edit source]
FL3 is a synthetic derivative of the natural product rocaglamide, which is a member of the flavagline class of compounds. Flavaglines are a group of compounds isolated from the plant genus Aglaia, known for their diverse biological activities.
Pharmacology[edit | edit source]
FL3 exhibits potent anti-cancer activity by inhibiting the synthesis of proteins necessary for tumor growth and survival. It acts by binding to the eukaryotic initiation factor 4A (eIF4A), an RNA helicase involved in the initiation of protein synthesis. By inhibiting eIF4A, FL3 disrupts the synthesis of proteins that are critical for cancer cell survival and proliferation.
In addition to its anti-cancer properties, FL3 has also been shown to have neuroprotective effects. It has been found to protect neurons from apoptosis (programmed cell death) induced by various stressors, suggesting potential applications in the treatment of neurodegenerative diseases.
Clinical Applications[edit | edit source]
The potent anti-cancer and neuroprotective properties of FL3 have led to its investigation as a potential therapeutic agent in a variety of clinical settings. Studies have shown that FL3 has potential therapeutic applications in the treatment of various types of cancer, including breast cancer, prostate cancer, and leukemia. In addition, its neuroprotective effects suggest potential applications in the treatment of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
Safety and Toxicity[edit | edit source]
As with any potential therapeutic agent, the safety and toxicity of FL3 are important considerations. Preclinical studies have shown that FL3 has a favorable safety profile, with low toxicity observed in animal models. However, further studies are needed to fully assess the safety and potential side effects of FL3 in humans.
See Also[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
